Endotoxin stuns cGMP-mediated pulmonary vasorelaxation

Area of Science:

• Pulmonary circulation physiology
• Endotoxin-induced inflammation
• Vascular smooth muscle pharmacology

Background:

• Pulmonary vascular tone relies on vasorelaxation and vasoconstriction balance.
• Endotoxemia impairs cGMP-mediated vasorelaxation via neutrophils, but vasoconstriction persists.
• Neutrophil presence in lungs and cardiac stunning is transient in other injury models.

Purpose of the Study:

• To investigate the reversibility of lung neutrophil accumulation and cGMP-mediated pulmonary vasorelaxation after endotoxin challenge.
• To examine endothelium-dependent and -independent vasorelaxation mechanisms at 4 and 48 hours post-endotoxin.
• To determine if endotoxin causes reversible dysfunction in vascular endothelial and smooth muscle cells.

Main Methods:

• Studied rats 4 and 48 hours after saline or endotoxin injection.
• Assessed lung neutrophil accumulation using myeloperoxidase assay.
• Measured endothelium-dependent (acetylcholine, A23187) and -independent (sodium nitroprusside) vasorelaxation in isolated pulmonary artery rings.

Main Results:

• Lung neutrophil accumulation increased at 4 hours and decreased by 48 hours post-endotoxin.
• Endotoxin-induced impairment of cGMP-mediated vasorelaxation (both endothelium-dependent and -independent) at 4 hours normalized by 48 hours.
• These findings indicate a transient effect of endotoxin on pulmonary vascular function.

Conclusions:

• Endotoxin challenge causes reversible lung neutrophil accumulation.
• The dysfunction in cGMP-mediated pulmonary vasorelaxation following endotoxemia is temporary.
• Endotoxin may reversibly 'stun' vascular endothelial and smooth muscle cells, leading to transient vasorelaxation impairment.